DEVELOPMENT OF RANIBIZUMAB, AN ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR ANTIGEN BINDING FRAGMENT, AS THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION-Reference-Cited by-同舟云学术

DEVELOPMENT OF RANIBIZUMAB, AN ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR ANTIGEN BINDING FRAGMENT, AS THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

Published:2006-10 Issue:8 Volume:26 Page:859-870
ISSN:0275-004X
Container-title:Retina
language:en
Short-container-title:

Author:

FERRARA NAPOLEONE,DAMICO LISA,SHAMS NAVEED,LOWMAN HENRY,KIM ROBERT

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology,General Medicine

Reference115 articles.

1. Vascular-specific growth factors and blood vessel formation.;Yancopoulos;Nature,2000

2. Angiogenesis in health and disease.;Carmeliet;Nat Med,2003

3. Molecular regulation of vessel maturation.;Jain;Nat Med,2003

4. Endogenous inhibitors of angiogenesis.;Nyberg;Cancer Res,2005

5. VEGF and the quest for tumour angiogenesis factors.;Ferrara;Nat Rev Cancer,2002

Cited by 719 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Severe Intraocular Inflammation After Intravitreal Injection of Faricimab: A Single-Site Case Series of Six Patients;American Journal of Ophthalmology;2025-01

2. References;The Evolution of Immunotherapy Against Tumors;2025

3. VEGF-A165a and angiopoietin-2 differently affect the barrier formed by retinal endothelial cells;Experimental Eye Research;2024-10

4. Intraocular drugs: pharmacokinetic strategies and the influence on efficacy and durability;Expert Opinion on Drug Metabolism & Toxicology;2024-09-11

5. Résultats anatomiques et fonctionnels du protocole thérapeutique « 3 + PRN » dans le traitement de l’œdème maculaire diabétique;Journal Français d'Ophtalmologie;2024-09